Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Understanding the polypharmacological anticancer effects of Xiao Chai Hu Tang via a computational pharmacological model.

Zheng CS, Wu YS, Bao HJ, Xu XJ, Chen XQ, Ye HZ, Wu GW, Xu HF, Li XH, Chen JS, Liu XX.

Exp Ther Med. 2014 Jun;7(6):1777-1783. Epub 2014 Apr 2.

2.

THE HERBAL MIXTURE XIAO-CHAI-HU TANG (XCHT) INDUCES APOPTOSIS OF HUMAN HEPATOCELLULAR CARCINOMA HUH7 CELLS IN VITRO AND IN VIVO.

Zhao J, Liu L, Zhang Y, Wan Y, Hong Z.

Afr J Tradit Complement Altern Med. 2017 Mar 1;14(3):231-241. doi: 10.21010/ajtcam.v14i3.25. eCollection 2017.

3.

Xiao-Chai-Hu Tang in treating model mice with D-galactosamine-induced liver injury.

Zhou YX, Qiu YQ, Xu LQ, Guo J, Li LJ.

Afr J Tradit Complement Altern Med. 2012 Apr 2;9(3):405-11. eCollection 2012.

4.

A Network-Based Pharmacology Study of the Herb-Induced Liver Injury Potential of Traditional Hepatoprotective Chinese Herbal Medicines.

Hong M, Li S, Tan HY, Cheung F, Wang N, Huang J, Feng Y.

Molecules. 2017 Apr 14;22(4). pii: E632. doi: 10.3390/molecules22040632.

5.

Current understanding on antihepatocarcinoma effects of xiao chai hu tang and its constituents.

Zheng N, Dai J, Cao H, Sun S, Fang J, Li Q, Su S, Zhang Y, Qiu M, Huang S.

Evid Based Complement Alternat Med. 2013;2013:529458. doi: 10.1155/2013/529458. Epub 2013 Jun 18.

6.

Serum metabonomics study of anti-depressive effect of Xiao-Chai-Hu-Tang on rat model of chronic unpredictable mild stress.

Xiong Z, Yang J, Huang Y, Zhang K, Bo Y, Lu X, Su G, Ma J, Yang J, Zhao L, Wu C.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Sep 1;1029-1030:28-35. doi: 10.1016/j.jchromb.2016.06.044. Epub 2016 Jun 27.

PMID:
27398633
8.

Renal protective effect of xiao-chai-hu-tang on diabetic nephropathy of type 1-diabetic mice.

Lin CC, Lin LT, Yen MH, Cheng JT, Hsing CH, Yeh CH.

Evid Based Complement Alternat Med. 2012;2012:984024. doi: 10.1155/2012/984024. Epub 2012 Mar 7.

9.

Xiao chai hu tang inhibits CVB1 virus infection of CCFS-1 cells through the induction of Type I interferon expression.

Cheng PW, Ng LT, Lin CC.

Int Immunopharmacol. 2006 Jun;6(6):1003-12. Epub 2006 Feb 21.

PMID:
16644487
10.

Ultrasound-assisted extraction methodology as a tool to improve the antioxidant properties of herbal drug Xiao-chia-hu-tang.

Liu CT, Wu CY, Weng YM, Tseng CY.

J Ethnopharmacol. 2005 Jun 3;99(2):293-300. Epub 2005 Apr 7.

PMID:
15894141
11.

Simultaneous determinations of 17 marker compounds in Xiao-Chai-Hu-Tang by LC-MS/MS: Application to its pharmacokinetic studies in mice.

Sun R, Zeng M, Du T, Li L, Yang G, Hu M, Gao S.

J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Oct 15;1003:12-21. doi: 10.1016/j.jchromb.2015.09.004. Epub 2015 Sep 11.

13.

Deciphering the underlying mechanisms of Diesun Miaofang in traumatic injury from a systems pharmacology perspective.

Zheng CS, Fu CL, Pan CB, Bao HJ, Chen XQ, Ye HZ, Ye JX, Wu GW, Li XH, Xu HF, Xu XJ, Liu XX.

Mol Med Rep. 2015 Aug;12(2):1769-76. doi: 10.3892/mmr.2015.3638. Epub 2015 Apr 16.

14.

A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chai-hu-tang) in chronic hepatitis C patients.

Deng G, Kurtz RC, Vickers A, Lau N, Yeung KS, Shia J, Cassileth B.

J Ethnopharmacol. 2011 Jun 14;136(1):83-7. doi: 10.1016/j.jep.2011.04.008. Epub 2011 Apr 17.

PMID:
21527335
15.

Acute hepatitis induced by Chinese hepatoprotective herb, xiao-chai-hu-tang.

Hsu LM, Huang YS, Tsay SH, Chang FY, Lee SD.

J Chin Med Assoc. 2006 Feb;69(2):86-8.

16.

Treatment of chronic liver injury in mice by oral administration of xiao-chai-hu-tang.

Amagaya S, Hayakawa M, Ogihara Y, Ohta Y, Fujiwara K, Oka H, Oshio H, Kishi T.

J Ethnopharmacol. 1989 Apr;25(2):181-7.

PMID:
2747252
17.

Effects of chai ling tang on proteinuria in rat models.

Li P, Fujio S.

J Tradit Chin Med. 1995 Mar;15(1):48-52.

PMID:
7783463
18.

Occurrence of chai hu (Bupleuri radix) in prescriptions of Chinese herbal medicine in Switzerland.

Klein SD, Becker S, Wolf U.

Forsch Komplementmed. 2012;19(5):242-6. doi: 10.1159/000343506. Epub 2012 Oct 5.

PMID:
23128098
19.

Supplemental Content

Support Center